Investigating the Relationship between the Infection Caused by Toxoplasma gondii and the Rate of Infection with Covid-19 Disease and Its Severity
-
Maryam Mozouni
,
Aliehsan Heidari
,
Shaghayegh Alipour Aval
,
Mehrab Asgary Valogerdi
,
Amir Bairami
,
Mahmood Bakhtiyari
,
Hossein Keshavarz
Abstract
No Abstract.
Geraili A, Badirzadeh A, Sadeghi M, et al. Toxoplasmosis and symptoms severity in patients with COVID-19 in referral centers in Northern Iran. J Parasit Dis. 2023;47(1):185-91.
2. Hasanzadeh M, Ahmadpour E, Mahami-Oskouei M, Musavi S, Parsaei M, Sarafraz N, Spotin A. Genetic diversity and seroprevalence of Toxoplasma gondii in COVID‑19 patients; a first case-control study in Iran. BMC Infect Dis. 2024;24(1):42.
3. Malary M, Hamzehgardeshi Z, Moosazadeh M, et al. Seroprevalence of Toxoplasma gondii infection among Iranian pregnant women: a systematic review and meta-analysis. East Mediterr Health J. 2018;17;24(5):488-496.
4. University JH. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) 2025 [October 13, 2025]. Available from: https://coronavirus.jhu.edu/region/iran
5. Zanza C, Romenskaya T, Manetti AC, et al. Cytokine Storm in COVID-19: Immunopathogenesis and Therapy. Medicina (Kaunas). 2022;58(2).
6. Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250-6.
7. Asfaram S, Iranpour S, Molaei S, Abdollahzadeh H, Faraji F, Aminizadeh S. Sero-prevalence of Toxoplasma gondii before and during the COVID-19 pandemic in Northwestern Iran. BMC Infect Dis. 2024;24(1):834.
2. Hasanzadeh M, Ahmadpour E, Mahami-Oskouei M, Musavi S, Parsaei M, Sarafraz N, Spotin A. Genetic diversity and seroprevalence of Toxoplasma gondii in COVID‑19 patients; a first case-control study in Iran. BMC Infect Dis. 2024;24(1):42.
3. Malary M, Hamzehgardeshi Z, Moosazadeh M, et al. Seroprevalence of Toxoplasma gondii infection among Iranian pregnant women: a systematic review and meta-analysis. East Mediterr Health J. 2018;17;24(5):488-496.
4. University JH. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) 2025 [October 13, 2025]. Available from: https://coronavirus.jhu.edu/region/iran
5. Zanza C, Romenskaya T, Manetti AC, et al. Cytokine Storm in COVID-19: Immunopathogenesis and Therapy. Medicina (Kaunas). 2022;58(2).
6. Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250-6.
7. Asfaram S, Iranpour S, Molaei S, Abdollahzadeh H, Faraji F, Aminizadeh S. Sero-prevalence of Toxoplasma gondii before and during the COVID-19 pandemic in Northwestern Iran. BMC Infect Dis. 2024;24(1):834.
| Files | ||
| Issue | Vol 21 No 2 (2026) | |
| Section | Letter to the Editor | |
| Keywords | ||
| . | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Mozouni M, Heidari A, Alipour Aval S, Asgary Valogerdi M, Bairami A, Bakhtiyari M, Keshavarz H. Investigating the Relationship between the Infection Caused by Toxoplasma gondii and the Rate of Infection with Covid-19 Disease and Its Severity. Iran J Parasitol. 2026;21(2):304-306.
